Evidence map›Paper›PMID 29367260›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2018

Sequencing analysis of the SCA6 CAG expansion excludes an influence of repeat interruptions on disease onset.

Sarah Wiethoff, Emer O'Connor, Nourelhoda A Haridy, Suran Nethisinghe, Nicholas Wood, Paola Giunti, Conceição Bettencourt, Henry Houlden

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah WiethoffDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Emer O'ConnorDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Nourelhoda A HaridyDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Suran NethisingheDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Nicholas WoodDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Paola GiuntiDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Conceição Bettencourt *Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.ORCID 0000-0001-9090-7690
Henry Houlden *Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.

Funding

Department of HealthMedical Research CouncilParkinson's UK G-1107Wellcome Trust WT093205 MAWellcome Trust WT104033AIA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Trinucleotide Repeat ExpansionCalcium ChannelsCalcium Channels, N-TypeDatabases, FactualDisease ProgressionHumansSpinocerebellar AtaxiasCACNA1A protein, humanCalcium ChannelsCalcium Channels, N-Typedisease modifying factorspolyglutamine diseasesrepeat interruptionsSpinocerebellar ataxia type 6trinucleotide repeat expansions

Identifiers

PMID29367260
PMCPMC6227801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.